Literature DB >> 16931330

URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain.

Susanna M Saario1, Ville Palomäki, Marko Lehtonen, Tapio Nevalainen, Tomi Järvinen, Jarmo T Laitinen.   

Abstract

Previous studies indicate that in brain tissue the endocannabinoid 2-AG is inactivated by monoglyceride lipase (MGL)-catalyzed hydrolysis, and a recent report has indicated that MGL activity could be specifically inhibited by URB754 . In the present study, URB754 failed to inhibit 2-AG hydrolysis in rat brain preparations. In addition, brain cryosections were employed to assess whether URB754 could facilitate the detection of 2-AG-stimulated G protein activity. Nevertheless, whereas pretreatment with PMSF readily allowed detection of 2-AG-stimulated G protein activity, URB754 was ineffective. In contrast to previous claims, brain FAAH activity was also resistant to URB754. Thus, in our hands URB754 was not able to block the endocannabinoid-hydrolyzing enzymes and cannot serve as a lead structure for future development of MGL-specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931330     DOI: 10.1016/j.chembiol.2006.07.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.

Authors:  Bin Pan; Wei Wang; Jonathan Z Long; Dalong Sun; Cecilia J Hillard; Benjamin F Cravatt; Qing-song Liu
Journal:  J Pharmacol Exp Ther       Date:  2009-08-07       Impact factor: 4.030

Review 3.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

4.  Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.

Authors:  S Vandevoorde; K-O Jonsson; G Labar; E Persson; D M Lambert; C J Fowler
Journal:  Br J Pharmacol       Date:  2006-12-04       Impact factor: 8.739

5.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

Review 6.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

7.  Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.

Authors:  Alex Straiker; Sherry Shu-Jung Hu; Jonathan Z Long; Andy Arnold; Jim Wager-Miller; Benjamin F Cravatt; Ken Mackie
Journal:  Mol Pharmacol       Date:  2009-09-18       Impact factor: 4.436

8.  Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.

Authors:  C J Hillard; W-Sv Ho; J Thompson; K M Gauthier; C E Wheelock; H Huang; B D Hammock
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

9.  A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.

Authors:  Jacqueline L Blankman; Gabriel M Simon; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2007-12

10.  URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices.

Authors:  Alvin R King; Andrea Duranti; Andrea Tontini; Silvia Rivara; Anja Rosengarth; Jason R Clapper; Giuseppe Astarita; Jennifer A Geaga; Hartmut Luecke; Marco Mor; Giorgio Tarzia; Daniele Piomelli
Journal:  Chem Biol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.